LG Chem eyes new leap into top science company
Samsung Biologics Q1 earnings hit all-time high
Celltrion sees market share of Remsima rising in European nations
Samsung Bioepis begins phase 3 clinical study for its Keytruda biosimilar
Pharmaceutical rivals partner for Fexuclue's sales
Samsung Bioepis launches half-priced Soliris biosimilar
Hanmi heirs may seek to repair with family first
Kolmar Korea makes R&D push for bigger footing globally
Hanmi-OCI merger called off
Korea’s CMO ramp-up lures biotech investors